|
1
|
Sherman SI: Thyroid carcinoma. Lancet.
361:501–511. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Olejarski J, Yang M and Varghese J:
Follicular thyroid carcinoma presenting as a soft tissue thigh
mass. Lancet Diabetes Endocrinol. 2:3482014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Spoto G, Esposito A, Santoleri F, Rubini
C, Rutjes AW, Fioroni M, Ferrante M and Petrini M: Does cyclic
guanosine monophosphate induce autophagy in thyroid malignant
carcinoma through down-regulation of cyclic guanosine monophosphate
phosphodiesterase? J Biol Regul Homeost Agents. 30:599–604.
2016.PubMed/NCBI
|
|
4
|
Lu YC, Lee YR, Liao JD, Lin CY, Chen YY,
Chen PT and Tseng YS: Reversine induced multinucleated cells, cell
apoptosis and autophagy in human Non-small cell lung cancer cells.
PLoS One. 11:e01585872016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saleh T, Cuttino L and Gewirtz DA:
Autophagy is not uniformly cytoprotective: A personalized medicine
approach for autophagy inhibition as a therapeutic strategy in
Non-small cell lung cancer. Biochim Biophys Acta. 1860:2130–2136.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen MC, Chen CH, Liu YN, Wang HP, Pan SL
and Teng CM: TW01001, a novel piperazinedione compound, induces
mitotic arrest and autophagy in non-small cell lung cancer A549
cells. Cancer Lett. 336:370–378. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Choi JY, Hong WG, Cho JH, Kim EM, Kim J,
Jung CH, Hwang SG, Um HD and Park JK: Podophyllotoxin acetate
triggers anticancer effects against non-small cell lung cancer
cells by promoting cell death via cell cycle arrest, ER stress and
autophagy. Int J Oncol. 47:1257–1265. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang C, Ma X, Wang Z, Zeng X, Hu Z, Ye Z
and Shen G: Curcumin induces apoptosis and protective autophagy in
castration-resistant prostate cancer cells through iron chelation.
Drug Des Devel Ther. 11:431–439. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen K and Shi W: Autophagy regulates
resistance of non-small cell lung cancer cells to paclitaxel.
Tumour Biol. 37:10539–10544. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen M, Du Y, Qui M, Wang M, Chen K, Huang
Z, Jiang M, Xiong F, Chen J, Zhou J, et al: Ophiopogonin B-induced
autophagy in non-small cell lung cancer cells via inhibition of the
PI3K/Akt signaling pathway. Oncol Rep. 29:430–436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma LN, Li LD, Li SC, Hao XM, Zhang JY, He
P and Li YK: Allicin improves the cardiac function by protecting
against apoptosis in rat model of myocardial infarction. Chin J
Integr Med. 23:589–597. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang H, Jiang Y, Mao G, Yuan F, Zheng H,
Ruan Y and Wu T: Protective effects of allicin on
streptozotocin-induced diabetic nephropathy in rats. J Sci Food
Agric. 97:1359–1366. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma T, Chen D, Tu Y, Zhang N, Si B, Deng K
and Diao Q: Effect of supplementation of allicin on methanogenesis
and ruminal microbial flora in Dorper crossbred ewes. J Anim Sci
Biotechnol. 7:12016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Muller A, Eller J, Albrecht F, Prochnow P,
Kuhlmann K, Bandow JE, Slusarenko AJ and Leichert LI: Allicin
induces thiol stress in bacteria through S-Allylmercapto
modification of protein cysteines. J Biol Chem. 291:11477–11490.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sheppard JG and Long TE: Allicin-inspired
thiolated fluoroquinolones as antibacterials against ESKAPE
pathogens. Bioorg Med Chem Lett. 26:5545–5549. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tu G, Zhang YF, Wei W, Li L, Zhang Y, Yang
J and Xing Y: Allicin attenuates H2O2-induced cytotoxicity in
retinal pigmented epithelial cells by regulating the levels of
reactive oxygen species. Mol Med Rep. 13:2320–2326. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang S and Ren D: Allicin protects
traumatic spinal cord injury through regulating the HSP70/Akt/iNOS
pathway in mice. Mol Med Rep. 14:3086–3092. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang W, Du Z, Nimiya Y, Sukamtoh E, Kim D
and Zhang G: Allicin inhibits lymphangiogenesis through suppressing
activation of vascular endothelial growth factor (VEGF) receptor. J
Nutr Biochem. 29:83–89. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Koleini N, Nickel BE, Wang J, Roveimiab Z,
Fandrich RR, Kirshenbaum LA, Cattini PA and Kardami E: Fibroblast
growth factor-2-mediated protection of cardiomyocytes from the
toxic effects of doxorubicin requires the mTOR/Nrf-2/HO-1 pathway.
Oncotarget. 8:87415–87430. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Giuffrida R, Adamo L, Iannolo G, Vicari L,
Giuffrida D, Eramo A, Gulisano M, Memeo L and Conticello C:
Resistance of papillary thyroid cancer stem cells to chemotherapy.
Oncol Lett. 12:687–691. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
de Groot S, Janssen LG, Charehbili A,
Dijkgraaf EM, Smit VT, Kessels LW, van Bochove A, van Laarhoven HW,
Meershoek-Klein Kranenbarg E, van Leeuwen-Stok AE, et al: Thyroid
function alters during neoadjuvant chemotherapy in breast cancer
patients: Results from the NEOZOTAC trial (BOOG 2010-01). Breast
Cancer Res Treat. 149:461–466. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Denaro N, Nigro CL, Russi EG and Merlano
MC: The role of chemotherapy and latest emerging target therapies
in anaplastic thyroid cancer. Onco Targets Ther. 9:1231–1241. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
De Besi P, Busnardo B, Toso S, Girelli ME,
Nacamulli D, Simioni N, Casara D, Zorat P and Fiorentino MV:
Combined chemotherapy with bleomycin, adriamycin, and platinum in
advanced thyroid cancer. J Endocrinol Invest. 14:475–480. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Droz JP, Rougier P, Goddefroy V,
Schlumberger M, Gardet P and Parmentier C: Chemotherapy for
medullary cancer of the thyroid. Phase II trials with adriamycin
and cis-platinum administered as monochemotherapy. Bull Cancer.
71:195–199. 1984.PubMed/NCBI
|
|
25
|
Tirro E, Consoli ML, Massimino M, Manzella
L, Frasca F, Sciacca L, Vicari L, Stassi G, Messina L, Messina A
and Vigneri P: Altered expression of c-IAP1, survivin, and Smac
contributes to chemotherapy resistance in thyroid cancer cells.
Cancer Res. 66:4263–4272. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Albero A, Lopéz JE, Torres A, de la Cruz L
and Martín T: Effectiveness of chemotherapy in advanced
differentiated thyroid cancer: A systematic review. Endocr Relat
Cancer. 23:R71–R84. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lacin S, Esin E, Karakas Y and Yalcin S:
Metastatic medullary thyroid cancer: A dramatic response to a
systemic chemotherapy (temozolomide and capecitabine) regimen. Onco
Targets Ther. 8:1039–1042. 2015.PubMed/NCBI
|
|
28
|
Ali AB, Nin DS, Tam J and Khan M: Role of
chaperone mediated autophagy (CMA) in the degradation of misfolded
N-CoR protein in non-small cell lung cancer (NSCLC) cells. PLoS
One. 6:e252682011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Giatromanolaki A, Kalamida D, Sivridis E,
Karagounis IV, Gatter KC, Harris AL and Koukourakis MI: Increased
expression of transcription factor EB (TFEB) is associated with
autophagy, migratory phenotype and poor prognosis in non-small cell
lung cancer. Lung Cancer. 90:98–105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo Q, Liu Z, Jiang L, Hu T, Li D, Liu Y,
Liu M, Liang X and Nan K: Starvation-induced autophagy in cultured
non-small cell lung cancer cells. Nan Fang Yi Ke Da Xue Xue Bao.
34:627–630. 2014.PubMed/NCBI
|
|
31
|
Wang W, Kang H, Zhao Y, Min I, Wyrwas B,
Moore M, Teng L, Zarnegar R, Jiang X and Fahey TJ III: Targeting
autophagy sensitizes BRAF-Mutant thyroid cancer to vemurafenib. J
Clin Endocrinol Metab. 102:634–643. 2017.PubMed/NCBI
|
|
32
|
Broecker-Preuss M, Viehof J, Jastrow H,
Becher-Boveleth N, Fuhrer D and Mann K: Cell death induction by the
BH3 mimetic GX15-070 in thyroid carcinoma cells. J Exp Clin Cancer
Res. 34:692015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hwang KE, Kim YS, Jung JW, Kwon SJ, Park
DS, Cha BK, Oh SH, Yoon KH, Jeong ET and Kim HR: Inhibition of
autophagy potentiates pemetrexed and simvastatin-induced apoptotic
cell death in malignant mesothelioma and non-small cell lung cancer
cells. Oncotarget. 6:29482–29496. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jeong EH, Choi HS, Lee TG, Kim HR and Kim
CH: Dual inhibition of PI3K/Akt/mTOR pathway and role of autophagy
in Non-small cell lung cancer cells. Tuberc Respir Dis (Seoul).
72:343–351. 2012. View Article : Google Scholar : PubMed/NCBI
|
